Viewing StudyNCT01621724



Ignite Creation Date: 2024-05-06 @ 12:39 AM
Last Modification Date: 2024-10-26 @ 10:52 AM
Study NCT ID: NCT01621724
Status: COMPLETED
Last Update Posted: 2018-10-02
First Post: 2012-03-22

Brief Title: WT1 TCR Gene Therapy for Leukaemia A Phase III Safety and Toxicity Study
Sponsor: Cell Medica Ltd
Organization: Cell Medica Ltd

Organization Data

Organization: Cell Medica Ltd
Class: INDUSTRY
Study ID: D-00272-CT2014001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Cell Medica Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Cell Therapy Catapult OTHER
University College London OTHER